Project Details
Description
A RANDOMIZED, DOUBLE-BLINDED, ACTIVE-CONTROLLED, DOSE RANGING STUDY OF CB-183,315 IN PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION
| Status | Finished |
|---|---|
| Effective start/end date | 1/29/10 → 12/31/20 |
Funding
- CUBIST PHARMACEUTICALS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.